Agan, Pedro .
HRN: 24-66-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/07/2024
03/13/2024
IV
4.5g
Q8
CAP MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes